Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Phytophotodermatitis: Rash with many faces.

Harshman J, Quan Y, Hsiang D.

Can Fam Physician. 2017 Dec;63(12):938-940. No abstract available.

2.

Emergency contraception.

Hsiang D, Dunn S.

CMAJ. 2016 Dec 6;188(17-18):E536. doi: 10.1503/cmaj.160720. Epub 2016 Nov 7. No abstract available.

3.

Utilizing Mohs Surgery for Tissue Preservation in Erosive Adenomatosis of the Nipple.

Brankov N, Nino T, Hsiang D, Zeineh L.

Dermatol Surg. 2016 May;42(5):684-6. doi: 10.1097/DSS.0000000000000677. No abstract available.

PMID:
27045746
4.

Long-term follow-up of breast-conserving therapy in patients with inflammatory breast cancer treated with neoadjuvant chemotherapy.

Bonev V, Evangelista M, Chen JH, Su MY, Lane K, Mehta R, Butler J, Hsiang D.

Am Surg. 2014 Oct;80(10):940-3.

5.

Next-generation sequencing reveals a Novel NSCLC ALK F1174V mutation and confirms ALK G1202R mutation confers high-level resistance to alectinib (CH5424802/RO5424802) in ALK-rearranged NSCLC patients who progressed on crizotinib.

Ignatius Ou SH, Azada M, Hsiang DJ, Herman JM, Kain TS, Siwak-Tapp C, Casey C, He J, Ali SM, Klempner SJ, Miller VA.

J Thorac Oncol. 2014 Apr;9(4):549-53. doi: 10.1097/JTO.0000000000000094.

6.

Impact of factors affecting the residual tumor size diagnosed by MRI following neoadjuvant chemotherapy in comparison to pathology.

Chen JH, Bahri S, Mehta RS, Carpenter PM, McLaren CE, Chen WP, Fwu PT, Hsiang DJ, Lane KT, Butler JA, Su MY.

J Surg Oncol. 2014 Feb;109(2):158-67. doi: 10.1002/jso.23470. Epub 2013 Oct 28.

7.

Can regional tattoos impact sentinel lymph node identification?

Datrice N, Wirth G, Hsiang D, Butler J, Lane KT.

Am Surg. 2013 Mar;79(3):331-2. No abstract available.

PMID:
23461966
8.

Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.

Ueda S, Roblyer D, Cerussi A, Durkin A, Leproux A, Santoro Y, Xu S, O'Sullivan TD, Hsiang D, Mehta R, Butler J, Tromberg BJ.

Cancer Res. 2012 Sep 1;72(17):4318-28. doi: 10.1158/0008-5472.CAN-12-0056. Epub 2012 Jul 9.

9.

Diagnostic performance of magnetic resonance imaging for assessing tumor response in patients with HER2-negative breast cancer receiving neoadjuvant chemotherapy is associated with molecular biomarker profile.

Kuzucan A, Chen JH, Bahri S, Mehta RS, Carpenter PM, Fwu PT, Yu HJ, Hsiang DJ, Lane KT, Butler JA, Feig SA, Su MY.

Clin Breast Cancer. 2012 Apr;12(2):110-8. doi: 10.1016/j.clbc.2012.01.009.

10.

Effects of motion on optical properties in the spatial frequency domain.

Nguyen JQ, Saager RB, Cuccia DJ, Kelly KM, Jakowatz J, Hsiang D, Durkin AJ.

J Biomed Opt. 2011 Dec;16(12):126009. doi: 10.1117/1.3662454.

11.

Preparation of highly pure zeaxanthin particles from sea water-cultivated microalgae using supercritical anti-solvent recrystallization.

Chen CR, Hong SE, Wang YC, Hsu SL, Hsiang D, Chang CM.

Bioresour Technol. 2012 Jan;104:828-31. doi: 10.1016/j.biortech.2011.11.083. Epub 2011 Nov 30.

PMID:
22169217
12.

Comparison of breast density measured on MR images acquired using fat-suppressed versus nonfat-suppressed sequences.

Chang DH, Chen JH, Lin M, Bahri S, Yu HJ, Mehta RS, Nie K, Hsiang DJ, Nalcioglu O, Su MY.

Med Phys. 2011 Nov;38(11):5961-8. doi: 10.1118/1.3646756.

13.

Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy.

Cerussi AE, Tanamai VW, Hsiang D, Butler J, Mehta RS, Tromberg BJ.

Philos Trans A Math Phys Eng Sci. 2011 Nov 28;369(1955):4512-30. doi: 10.1098/rsta.2011.0279.

14.

Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.

Chen JH, Bahri S, Mehta RS, Kuzucan A, Yu HJ, Carpenter PM, Feig SA, Lin M, Hsiang DJ, Lane KT, Butler JA, Nalcioglu O, Su MY.

Radiology. 2011 Dec;261(3):735-43. doi: 10.1148/radiol.11110814. Epub 2011 Aug 30.

15.

Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment.

Roblyer D, Ueda S, Cerussi A, Tanamai W, Durkin A, Mehta R, Hsiang D, Butler JA, McLaren C, Chen WP, Tromberg B.

Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14626-31. doi: 10.1073/pnas.1013103108. Epub 2011 Aug 18.

16.

Frequent optical imaging during breast cancer neoadjuvant chemotherapy reveals dynamic tumor physiology in an individual patient.

Cerussi AE, Tanamai VW, Mehta RS, Hsiang D, Butler J, Tromberg BJ.

Acad Radiol. 2010 Aug;17(8):1031-9. doi: 10.1016/j.acra.2010.05.002. Epub 2010 Jun 12.

17.

Characterization of metabolic differences between benign and malignant tumors: high-spectral-resolution diffuse optical spectroscopy.

Kukreti S, Cerussi AE, Tanamai W, Hsiang D, Tromberg BJ, Gratton E.

Radiology. 2010 Jan;254(1):277-84. doi: 10.1148/radiol.09082134.

18.

Effect of contact force on breast tissue optical property measurements using a broadband diffuse optical spectroscopy handheld probe.

Cerussi A, Siavoshi S, Durkin A, Chen C, Tanamai W, Hsiang D, Tromberg BJ.

Appl Opt. 2009 Jul 20;48(21):4270-7.

19.

Diffuse optical spectroscopy measurements of healing in breast tissue after core biopsy: case study.

Tanamai W, Chen C, Siavoshi S, Cerussi A, Hsiang D, Butler J, Tromberg B.

J Biomed Opt. 2009 Jan-Feb;14(1):014024. doi: 10.1117/1.3028012.

20.

Impact of MRI-evaluated neoadjuvant chemotherapy response on change of surgical recommendation in breast cancer.

Chen JH, Feig BA, Hsiang DJ, Butler JA, Mehta RS, Bahri S, Nalcioglu O, Su MY.

Ann Surg. 2009 Mar;249(3):448-54. doi: 10.1097/SLA.0b013e31819a6e01.

21.

In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy.

Chung SH, Cerussi AE, Klifa C, Baek HM, Birgul O, Gulsen G, Merritt SI, Hsiang D, Tromberg BJ.

Phys Med Biol. 2008 Dec 7;53(23):6713-27. doi: 10.1088/0031-9155/53/23/005. Epub 2008 Nov 7.

22.

Regional differences in the use of sentinel lymph node biopsy for melanoma: a potential quality measure.

Lane K, Kempf A, Magno C, Lane J, Butler J, Hsiang D, Greenfield S, Jakowatz J.

Am Surg. 2008 Oct;74(10):981-4.

PMID:
18942627
23.

Diffuse optical monitoring of blood flow and oxygenation in human breast cancer during early stages of neoadjuvant chemotherapy.

Zhou C, Choe R, Shah N, Durduran T, Yu G, Durkin A, Hsiang D, Mehta R, Butler J, Cerussi A, Tromberg BJ, Yodh AG.

J Biomed Opt. 2007 Sep-Oct;12(5):051903.

PMID:
17994886
24.

MRI features of breast cancer: a correlation study with HER-2 receptor.

Agrawal G, Chen JH, Baek HM, Hsiang D, Mehta RS, Nalcioglu O, Su MY.

Ann Oncol. 2007 Nov;18(11):1903-4. No abstract available. Erratum in: Ann Oncol. 2008 Jan;19(1):197.

PMID:
17993631
25.

Do breast columnar cell lesions with atypia need to be excised?

Datrice N, Narula N, Maggard M, Butler J, Hsiang D, Baick C, Lane K.

Am Surg. 2007 Oct;73(10):984-6.

PMID:
17983063
26.

The predictive value of sentinel lymph node biopsy in locally advanced breast cancer patients who have undergone neoadjuvant chemotherapy.

Yamamoto M, Mehta RS, Baick CH, Su MY, Lane KT, Butler JA, Hsiang DJ.

Am Surg. 2007 Oct;73(10):977-80.

PMID:
17983061
27.
28.

Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy.

Cerussi A, Hsiang D, Shah N, Mehta R, Durkin A, Butler J, Tromberg BJ.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4014-9. Epub 2007 Feb 28.

29.

In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy.

Cerussi A, Shah N, Hsiang D, Durkin A, Butler J, Tromberg BJ.

J Biomed Opt. 2006 Jul-Aug;11(4):044005.

PMID:
16965162
30.

Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy.

Tromberg BJ, Cerussi A, Shah N, Compton M, Durkin A, Hsiang D, Butler J, Mehta R.

Breast Cancer Res. 2005;7(6):279-85. Epub 2005 Nov 28. Review.

31.

Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer.

Hsiang D, Shah N, Yu H, Su MY, Cerussi A, Butler J, Baick C, Mehta R, Nalcioglu O, Tromberg B.

Technol Cancer Res Treat. 2005 Oct;4(5):549-58.

PMID:
16173825
32.

Pancreatic schwannoma. A case report and review of the literature.

Bui TD, Nguyen T, Huerta S, Gu M, Hsiang D.

JOP. 2004 Nov 10;5(6):520-6. Review.

33.

Spatial variations in optical and physiological properties of healthy breast tissue.

Shah N, Cerussi AE, Jakubowski D, Hsiang D, Butler J, Tromberg BJ.

J Biomed Opt. 2004 May-Jun;9(3):534-40.

34.

The role of diffuse optical spectroscopy in the clinical management of breast cancer.

Shah N, Cerussi AE, Jakubowski D, Hsiang D, Butler J, Tromberg BJ.

Dis Markers. 2003-2004;19(2-3):95-105. Review.

35.

Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study.

Jakubowski DB, Cerussi AE, Bevilacqua F, Shah N, Hsiang D, Butler J, Tromberg BJ.

J Biomed Opt. 2004 Jan-Feb;9(1):230-8.

36.

Spectroscopy enhances the information content of optical mammography.

Cerussi AE, Jakubowski D, Shah N, Bevilacqua F, Lanning R, Berger AJ, Hsiang D, Butler J, Holcombe RF, Tromberg BJ.

J Biomed Opt. 2002 Jan;7(1):60-71.

37.
38.

Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis.

Hsiang D, Friess H, B├╝chler MW, Ebert M, Butler J, Korc M.

Am J Surg. 1997 Sep;174(3):242-6.

PMID:
9324130

Supplemental Content

Loading ...
Support Center